Skip to content
  • Join Us
  • Members Area
ASOI
  • Home
  • ASOI News
  • About Us
  • Events
  • Media Resources
  • Public Resources
  • Guidelines
  • Research

Publication Category: Medications

Real world use of tirzepatide in the treatment of type 2 diabetes in an Arab population

  • Buckley A, Suliman S, Allum M, Mohammed N, Lessan N, le Roux CW, Suliman M. Real world use of tirzepatide in the treatment of type 2 diabetes in an Arab population Diabetes Obes Metab

    Insulin Resistance & Diabetes

NPYR modulation: Potential for the next major advance in obesity and type 2 diabetes management?

  • Lafferty RA, Flatt PR, Irwin N. NPYR modulation: Potential for the next major advance in obesity and type 2 diabetes management? Peptides

    Genetics Gut-Brain Insulin Resistance & Diabetes

Editorial: The rise and rise of peptide therapeutics for obesity-diabetes

  • Flatt PR, Conlon JM. Editorial: The rise and rise of peptide therapeutics for obesity-diabetes Peptides

Does glucose-dependent insulinotropic polypeptide receptor blockade as well as agonism have a role to play in management of obesity and diabetes?

  • Lafferty RA, Flatt PR, Gault VA, Irwin N. Does glucose-dependent insulinotropic polypeptide receptor blockade as well as agonism have a role to play in management of obesity and diabetes? J Endocrinol

Metabolic effects of very-low calorie diet, Semaglutide, or combination of the two, in individuals with type 2 diabetes mellitus

  • Anyiam O, Phillips B, Quinn K, Wilkinson D, Smith K, Atherton P, Idris I. Metabolic effects of very-low calorie diet, Semaglutide, or combination of the two, in individuals with type 2 diabetes mellitus Clin Nutr

    Insulin Resistance & Diabetes

Impact of insulin sensitization on metabolic and fertility outcomes in women with polycystic ovary syndrome and overweight or obesity-A systematic review, meta-analysis, and meta-regression

  • Samarasinghe SNS, Ostarijas E, Long MJ, Erridge S, Purkayastha S, Dimitriadis GK, Miras AD. Impact of insulin sensitization on metabolic and fertility outcomes in women with polycystic ovary syndrome and overweight or obesity-A systematic review, meta-analysis, and meta-regression Obes Rev

    PCOS

Metformin co-commencement at time of antipsychotic initiation for attenuation of weight gain: a systematic review and meta-analysis

  • Yu O, Lu M, Lai TKY, Hahn M, Agarwal SM, O'Donoghue B, Ebdrup BH, Siskind D. Metformin co-commencement at time of antipsychotic initiation for attenuation of weight gain: a systematic review and meta-analysis Ther Adv Psychopharmacol

    Metabolic Syndrome

Shifting the Scales: Tirzepatide’s Breakthrough in Obesity Management

  • Sallam M, Snygg J, Allam D, Kassem R. Shifting the Scales: Tirzepatide’s Breakthrough in Obesity Management Cureus

Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration

  • Galofré JC, Díez JJ, Attanasio R, Nagy EV, Negro R, Papini E, Perros P, Žarković M, Akarsu E, Alevizaki M, Ayvaz G, Bednarczuk T, Beleslin BN, Berta E, Bodor M, Borissova AM, Boyanov M, Buffet C, Burlacu MC, Dobnig H, Fadeyev V, Field BCT, Fliers E, Führe Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration J Endocrinol Invest

Does glucose-dependent insulinotropic polypeptide receptor blockade as well as agonism have a role to play in management of obesity and diabetes?

  • Lafferty RA, Flatt PR, Gault VA, Irwin N. Does glucose-dependent insulinotropic polypeptide receptor blockade as well as agonism have a role to play in management of obesity and diabetes? J Endocrinol

    Insulin Resistance & Diabetes

Older posts
Newer posts
← Previous Page1 … Page4 Page5 Page6 … Page23 Next →

Recent Posts

  • 9th ASOI Annual Conference – Registration now open!
  • Press Release for World Obesity Day 4th March 2024
  • ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
  • Things to do in Dublin during ECO
  • ECO 2023 sponsorship update

ASOI

  • info@asoi.info
  • Home
  • ASOI News
  • About Us
  • Events
  • Media Resources
  • Public Resources
  • Guidelines
  • Research
  • Home
  • ASOI News
  • About Us
  • Events
  • Media Resources
  • Public Resources
  • Guidelines
  • Research
  • Privacy Policy
  • Site Map

©2025 ASOI